ELV Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

423.910

Open

415.760

VWAP

421.15

Vol

52.30K

Mkt Cap

90.36B

Low

415.760

Amount

22.03M

EV/EBITDA(TTM)

12.29

Total Shares

217.16M

113.28B

EV/OCF(TTM)

14.90

P/S(TTM)

0.47

Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.

Events Timeline

(ET)

2026-06-23

11:00:00

Justice Department to Charge 450 Defendants in $6.5B Healthcare Fraud

2026-06-23

08:30:00

Elevance Health Launches Health OS to Enhance Clinical Review Efficiency

News

8.5

07-08seekingalpha

2027 Health Insurance Premiums May Rise 14%

6.5

07-08Yahoo Finance

Cash-Generating Stocks with Growth Potential

7.0

07-03NASDAQ.COM

Elevance Health Sues CMS Over Medicare Advantage Ratings

7.5

06-26NASDAQ.COM

Plus Therapeutics Signs Agreement with Elevance Health for CNSide Assay

7.5

06-25seekingalpha

Plus Therapeutics Partners with Elevance Health for Cancer Screening Test Coverage Expansion

8.5

06-24Newsfilter

Elevance Health and IFF Transform School Fitness Space

15 Analyst Rating

Wall Street analysts forecast ELV stock price to rise

11 Buy

4 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

332.00

Averages

389.07

High

425.00

Current: 0.000

Low

332.00

Averages

389.07

High

425.00

Cantor Fitzgerald

Sarah James

Overweight

maintain

$400 -> $450

AI Analysis

2026-07-07

New

Reason

Cantor Fitzgerald

Sarah James

Price Target

$400 -> $450

AI Analysis

2026-07-07

New

maintain

Overweight

Reason

Cantor Fitzgerald analyst Sarah James raised the firm's price target on Elevance Health to $450 from $400 and keeps an Overweight rating on the shares. Cantor prefers payors over providers heading into Q2 earnings, supported by management discussions, proprietary checks, and investor conversations, the analyst tells investors in a research note. Payors appear better positioned with continued strength in government insurance lines and VBC opportunities, while provider commentary may struggle to meet elevated expectations, limiting upside despite potential guidance increases, the firm says.

Bernstein

Outperform

maintain

$424 -> $482

2026-07-02

Reason

Bernstein

Price Target

$424 -> $482

2026-07-02

maintain

Outperform

Reason

Bernstein raised the firm's price target on Elevance Health to $482 from $424 and keeps an Outperform rating on the shares. The firm expects Elevance to report Q2 adjusted EPS of $6.38, and MLR of 89.9%. Further, Bernstein expects strong MA performance and modestly better prior period development to drive a modest MLR beat. The firm believes Medicaid and Marketplace are more likely to perform in line with the relatively conservative guidance.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ELV

Unlock Now

Valuation Metrics

The current forward P/E ratio for Elevance Health Inc (ELV.N) is 15.24, compared to its 5-year average forward P/E of 13.75. For a more detailed relative valuation and DCF analysis to assess Elevance Health Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

13.75

Current PE

15.24

Overvalued PE

15.56

Undervalued PE

11.93

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

10.33

Current EV/EBITDA

9.38

Overvalued EV/EBITDA

11.89

Undervalued EV/EBITDA

8.77

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

0.59

Current PS

0.46

Overvalued PS

0.73

Undervalued PS

0.45

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

which stocks to buy short term

Intellectia · 40 candidates

Moving Average Relationship: PriceAboveMA20Week Price Change Pct: $4.00 - $12.00Is Index Component: GSPC

Ticker

Name

Market Cap$

ELV

Elevance Health Inc

74.87B

QCOM

Qualcomm Inc

158.82B

VTR

Ventas Inc

39.76B

KDP

Keurig Dr Pepper Inc

39.76B

PKG

Packaging Corp of America

18.95B

BKR

Baker Hughes Co

68.37B

mejores acciones para comprar está semana?

Intellectia · 6 candidates

Month Price Change Pct: $0.00 - $20.00Is Index Component: GSPCOne Week Rise Prob: >= 60One Week Predict Return: >= 3.0%Monthly Average Dollar Volume: >= 1,000,000

Ticker

Name

Market Cap$

HAL

Halliburton Co

32.88B

ELV

Elevance Health Inc

62.56B

ADM

Archer-Daniels-Midland Co

34.58B

ALB

Albemarle Corp

20.89B

Blackstone Inc

87.40B

FOXA

Fox Corp

25.15B

what stock should I buy

Intellectia · 91 candidates

Region: USAnalyst Consensus: Strong Buy, Moderate BuyRevenue 5yr Cagr: >= 8Pe Ttm: 10 - 35List Exchange: XNYS, XNAS, XASETarget Price Upside Potential: MoreAbovePrice, AbovePriceIs Index Component: GSPC

Ticker

Name

Market Cap$

AMZN

Amazon.com Inc

2.20T

HST

Host Hotels & Resorts Inc

12.79B

UBER

Uber Technologies Inc

152.07B

General Motors Co

65.82B

RSG

Republic Services Inc

67.72B

LVS

Las Vegas Sands Corp

35.56B

top stocks in health sector

Intellectia · 38 candidates

Market Cap: >= 10.00BSector: Healthcare, Healthcare Services & EquipmentIndustry: Biotechnology & Medical Research, Healthcare Equipment & Supplies, Healthcare Providers & Services, PharmaceuticalsAnalyst Consensus: Strong Buy, Moderate BuyRevenue 5yr Cagr: >= 5List Exchange: XNYS, XNAS, XASEReturn On Equity: >= 10.0%

Ticker

Name

Market Cap$

LLY

Eli Lilly and Co

866.87B

ABBV

AbbVie Inc

364.65B

AZN

AstraZeneca PLC

293.00B

MRK

Merck & Co Inc

282.35B

UNH

UnitedHealth Group Inc

254.55B

AMGN

Amgen Inc

188.63B

titoli sotto quotati

Intellectia · 24 candidates

Market Cap: >= 2.00BPe Ttm: 5 - 18List Exchange: XNYS, XNAS, XASEP/B Ratio: <= 2.00Return On Equity: >= 10.0%Target Price Upside Potential: MoreAbovePrice

Ticker

Name

Market Cap$

ELV

Elevance Health Inc

64.46B

HBAN

Huntington Bancshares Inc

31.02B

DIS

Walt Disney Co

174.78B

MHO

M/I Homes Inc

3.33B

Axos Financial Inc

4.79B

LAD

Lithia Motors Inc

5.88B

who has earnings today’s

Intellectia · 83 candidates

List Exchange: XNYS, XNAS, XASE

Ticker

Name

Market Cap$

MSFT

Microsoft Corp

3.52T

Whales Holding ELV

Bellevue Asset Management AG

Crestline Investors Inc.

Ampega Investment GmbH

Jackson National Asset Management, LLC

Trading Trends

People Also Watch

Frequently Asked Questions

What is Elevance Health Inc (ELV) stock price today?

The current price of ELV is 423.765 USD — it has increased 1.85

What is Elevance Health Inc (ELV)'s business?

What is the price predicton of ELV Stock?

Wall Street analysts forecast ELV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ELV is389.07 USD with a low forecast of 332.00 USD and a high forecast of 425.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.